On Friday, Viridian Therapeutics Inc (VRDN) stock saw a decline, ending the day at $20.14 which represents a decrease of $-1.50 or -6.93% from the prior close of $21.64. The stock opened at $21.72 and ...

Not for distribution to U.S. news wire services or for dissemination in the United States VANCOUVER, British Columbia, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Viridian Metals Inc. (TSXV:VRDN) (the "Company" ...

Leerink Partners analyst Thomas Smith reiterated a Buy rating on Viridian Therapeutics (VRDN – Research Report) on November 12 and set a ...

H.C. Wainwright analyst Douglas Tsao maintained a Buy rating on Viridian Therapeutics (VRDN – Research Report) today and set a price ...

Third Quarter 2024 Results Key Financial Results Net loss: US$76.7m (loss ...

Needham has recently reiterated Viridian Therapeutics Inc (VRDN) stock to Buy rating, as announced on September 11, 2024, according to Finviz. Earlier, on June 11, 2024, Wolfe Research had initiated ...

Viridian Therapeutics, Inc. (VRDN) came out with a quarterly loss of $1.15 per share versus the Zacks Consensus Estimate of a loss of $1.11. This compares to loss of $1.09 per share a year ago. These ...

Cannabis stocks experienced a huge decline following the failure of Florida’s recreational marijuana ballot initiative, ...

Galway’s Tynagh mine – once one of the biggest employers in the West – could be destined for a new lease of life with plans by its new owner to recover metals from old mining waste and to kick off new ...

The artist is known for her almost stubborn devotion to small-scale paintings and her bold embrace of a viridian green ...